Roche Holding AG Shares Dip 1.5% as Market Shifts, But Pipeline Momentum Remains Strong
Roche Holding AG shares dip 1.5% amid market wobble, but the firm’s robust pipeline—targeted oncology, gene‑therapy for rare diseases, and antiviral breakthroughs—keeps investors hopeful for strong future growth.
5 minutes to read